Global Biodurable Ophthalmic Drug Delivery System Production, Demand and Key Producers, 2022-2028
Biodurable implants do not break down over time and may be removed or refilled once the treatment is complete.
This report studies the global Biodurable Ophthalmic Drug Delivery System production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biodurable Ophthalmic Drug Delivery System, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biodurable Ophthalmic Drug Delivery System that contribute to its increasing demand across many markets.
The global Biodurable Ophthalmic Drug Delivery System market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Biodurable Ophthalmic Drug Delivery System total production and demand, 2017-2028, (K Units)
Global Biodurable Ophthalmic Drug Delivery System total production value, 2017-2028, (USD Million)
Global Biodurable Ophthalmic Drug Delivery System production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Biodurable Ophthalmic Drug Delivery System consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Biodurable Ophthalmic Drug Delivery System domestic production, consumption, key domestic manufacturers and share
Global Biodurable Ophthalmic Drug Delivery System production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Biodurable Ophthalmic Drug Delivery System production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Biodurable Ophthalmic Drug Delivery System production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Biodurable Ophthalmic Drug Delivery System market based on the following parameters – headquarters, production locations, products portfolio, Biodurable Ophthalmic Drug Delivery System revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biodurable Ophthalmic Drug Delivery System market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Biodurable Ophthalmic Drug Delivery System Market, By Region:
1. How big is the global Biodurable Ophthalmic Drug Delivery System market?
2. What is the demand of the global Biodurable Ophthalmic Drug Delivery System market?
3. What is the year over year growth of the global Biodurable Ophthalmic Drug Delivery System market?
4. What is the production and production value of the global Biodurable Ophthalmic Drug Delivery System market?
5. Who are the key producers in the global Biodurable Ophthalmic Drug Delivery System market?
6. What are the growth factors driving the market demand?
This report studies the global Biodurable Ophthalmic Drug Delivery System production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biodurable Ophthalmic Drug Delivery System, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biodurable Ophthalmic Drug Delivery System that contribute to its increasing demand across many markets.
The global Biodurable Ophthalmic Drug Delivery System market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Biodurable Ophthalmic Drug Delivery System total production and demand, 2017-2028, (K Units)
Global Biodurable Ophthalmic Drug Delivery System total production value, 2017-2028, (USD Million)
Global Biodurable Ophthalmic Drug Delivery System production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Biodurable Ophthalmic Drug Delivery System consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Biodurable Ophthalmic Drug Delivery System domestic production, consumption, key domestic manufacturers and share
Global Biodurable Ophthalmic Drug Delivery System production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Biodurable Ophthalmic Drug Delivery System production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Biodurable Ophthalmic Drug Delivery System production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Biodurable Ophthalmic Drug Delivery System market based on the following parameters – headquarters, production locations, products portfolio, Biodurable Ophthalmic Drug Delivery System revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biodurable Ophthalmic Drug Delivery System market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Biodurable Ophthalmic Drug Delivery System Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Anterior Drug Delivery Methods
- Posterior Drug Delivery Methods
- Hospitals
- Clinics
- Others
- Glaukos Corp
- Ocular Therapeutix
- Santen Pharmaceutical
- pSivida
- Clearside Biomedical
- Bausch Health
- AptarGroup
- Boehringer Ingelheim
- Allergan
- Re-Vana Therapeutics
- PolyActiva
- Genentech
1. How big is the global Biodurable Ophthalmic Drug Delivery System market?
2. What is the demand of the global Biodurable Ophthalmic Drug Delivery System market?
3. What is the year over year growth of the global Biodurable Ophthalmic Drug Delivery System market?
4. What is the production and production value of the global Biodurable Ophthalmic Drug Delivery System market?
5. Who are the key producers in the global Biodurable Ophthalmic Drug Delivery System market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Biodurable Ophthalmic Drug Delivery System Introduction
1.2 World Biodurable Ophthalmic Drug Delivery System Supply & Forecast
1.2.1 World Biodurable Ophthalmic Drug Delivery System Production Value (2017 & 2021 & 2028)
1.2.2 World Biodurable Ophthalmic Drug Delivery System Production (2017-2028)
1.2.3 World Biodurable Ophthalmic Drug Delivery System Pricing Trends (2017-2028)
1.3 World Biodurable Ophthalmic Drug Delivery System Production by Region
1.3.1 World Biodurable Ophthalmic Drug Delivery System Production Value by Region (2017-2028)
1.3.2 World Biodurable Ophthalmic Drug Delivery System Production by Region (2017-2028)
1.3.3 World Biodurable Ophthalmic Drug Delivery System Average Price by Region (2017-2028)
1.3.4 North America Biodurable Ophthalmic Drug Delivery System Production (2017-2028)
1.3.5 Europe Biodurable Ophthalmic Drug Delivery System Production (2017-2028)
1.3.6 China Biodurable Ophthalmic Drug Delivery System Production (2017-2028)
1.3.7 Japan Biodurable Ophthalmic Drug Delivery System Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biodurable Ophthalmic Drug Delivery System Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biodurable Ophthalmic Drug Delivery System Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Biodurable Ophthalmic Drug Delivery System Demand (2017-2028)
2.2 World Biodurable Ophthalmic Drug Delivery System Consumption by Region
2.2.1 World Biodurable Ophthalmic Drug Delivery System Consumption by Region (2017-2022)
2.2.2 World Biodurable Ophthalmic Drug Delivery System Consumption Forecast by Region (2023-2028)
2.3 United States Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028)
2.4 China Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028)
2.5 Europe Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028)
2.6 Japan Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028)
2.7 South Korea Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028)
2.8 ASEAN Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028)
2.9 India Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028)
3 WORLD BIODURABLE OPHTHALMIC DRUG DELIVERY SYSTEM MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Biodurable Ophthalmic Drug Delivery System Production Value by Manufacturer (2017-2022)
3.2 World Biodurable Ophthalmic Drug Delivery System Production by Manufacturer (2017-2022)
3.3 World Biodurable Ophthalmic Drug Delivery System Average Price by Manufacturer (2017-2022)
3.4 Biodurable Ophthalmic Drug Delivery System Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Biodurable Ophthalmic Drug Delivery System Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Biodurable Ophthalmic Drug Delivery System in 2021
3.5.3 Global Concentration Ratios (CR8) for Biodurable Ophthalmic Drug Delivery System in 2021
3.6 Biodurable Ophthalmic Drug Delivery System Market: Overall Company Footprint Analysis
3.6.1 Biodurable Ophthalmic Drug Delivery System Market: Region Footprint
3.6.2 Biodurable Ophthalmic Drug Delivery System Market: Company Product Type Footprint
3.6.3 Biodurable Ophthalmic Drug Delivery System Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Biodurable Ophthalmic Drug Delivery System Production Value Comparison
4.1.1 United States VS China: Biodurable Ophthalmic Drug Delivery System Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Biodurable Ophthalmic Drug Delivery System Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Biodurable Ophthalmic Drug Delivery System Production Comparison
4.2.1 United States VS China: Biodurable Ophthalmic Drug Delivery System Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Biodurable Ophthalmic Drug Delivery System Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Biodurable Ophthalmic Drug Delivery System Consumption Comparison
4.3.1 United States VS China: Biodurable Ophthalmic Drug Delivery System Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Biodurable Ophthalmic Drug Delivery System Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Biodurable Ophthalmic Drug Delivery System Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Biodurable Ophthalmic Drug Delivery System in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Biodurable Ophthalmic Drug Delivery System Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Biodurable Ophthalmic Drug Delivery System Production by Domestic Manufacturer, (2017-2022)
4.5 China Biodurable Ophthalmic Drug Delivery System Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Biodurable Ophthalmic Drug Delivery System in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Biodurable Ophthalmic Drug Delivery System Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Biodurable Ophthalmic Drug Delivery System Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Biodurable Ophthalmic Drug Delivery System Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Biodurable Ophthalmic Drug Delivery System in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Biodurable Ophthalmic Drug Delivery System Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Biodurable Ophthalmic Drug Delivery System Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Biodurable Ophthalmic Drug Delivery System Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Anterior Drug Delivery Methods
5.2.2 Posterior Drug Delivery Methods
5.3 Market Segment by Type
5.3.1 World Biodurable Ophthalmic Drug Delivery System Production by Type (2017-2028)
5.3.2 World Biodurable Ophthalmic Drug Delivery System Production Value by Type (2017-2028)
5.3.3 World Biodurable Ophthalmic Drug Delivery System Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biodurable Ophthalmic Drug Delivery System Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Biodurable Ophthalmic Drug Delivery System Production by Application (2017-2028)
6.3.2 World Biodurable Ophthalmic Drug Delivery System Production Value by Application (2017-2028)
6.3.3 World Biodurable Ophthalmic Drug Delivery System Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Glaukos Corp
7.1.1 Glaukos Corp Details
7.1.2 Glaukos Corp Major Business
7.1.3 Glaukos Corp Biodurable Ophthalmic Drug Delivery System Product and Services
7.1.4 Glaukos Corp Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Glaukos Corp Recent Developments/Updates
7.1.6 Glaukos Corp Competitive Strengths & Weaknesses
7.2 Ocular Therapeutix
7.2.1 Ocular Therapeutix Details
7.2.2 Ocular Therapeutix Major Business
7.2.3 Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System Product and Services
7.2.4 Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Ocular Therapeutix Recent Developments/Updates
7.2.6 Ocular Therapeutix Competitive Strengths & Weaknesses
7.3 Santen Pharmaceutical
7.3.1 Santen Pharmaceutical Details
7.3.2 Santen Pharmaceutical Major Business
7.3.3 Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System Product and Services
7.3.4 Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Santen Pharmaceutical Recent Developments/Updates
7.3.6 Santen Pharmaceutical Competitive Strengths & Weaknesses
7.4 pSivida
7.4.1 pSivida Details
7.4.2 pSivida Major Business
7.4.3 pSivida Biodurable Ophthalmic Drug Delivery System Product and Services
7.4.4 pSivida Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 pSivida Recent Developments/Updates
7.4.6 pSivida Competitive Strengths & Weaknesses
7.5 Clearside Biomedical
7.5.1 Clearside Biomedical Details
7.5.2 Clearside Biomedical Major Business
7.5.3 Clearside Biomedical Biodurable Ophthalmic Drug Delivery System Product and Services
7.5.4 Clearside Biomedical Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Clearside Biomedical Recent Developments/Updates
7.5.6 Clearside Biomedical Competitive Strengths & Weaknesses
7.6 Bausch Health
7.6.1 Bausch Health Details
7.6.2 Bausch Health Major Business
7.6.3 Bausch Health Biodurable Ophthalmic Drug Delivery System Product and Services
7.6.4 Bausch Health Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Bausch Health Recent Developments/Updates
7.6.6 Bausch Health Competitive Strengths & Weaknesses
7.7 AptarGroup
7.7.1 AptarGroup Details
7.7.2 AptarGroup Major Business
7.7.3 AptarGroup Biodurable Ophthalmic Drug Delivery System Product and Services
7.7.4 AptarGroup Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 AptarGroup Recent Developments/Updates
7.7.6 AptarGroup Competitive Strengths & Weaknesses
7.8 Boehringer Ingelheim
7.8.1 Boehringer Ingelheim Details
7.8.2 Boehringer Ingelheim Major Business
7.8.3 Boehringer Ingelheim Biodurable Ophthalmic Drug Delivery System Product and Services
7.8.4 Boehringer Ingelheim Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Boehringer Ingelheim Recent Developments/Updates
7.8.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.9 Allergan
7.9.1 Allergan Details
7.9.2 Allergan Major Business
7.9.3 Allergan Biodurable Ophthalmic Drug Delivery System Product and Services
7.9.4 Allergan Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Allergan Recent Developments/Updates
7.9.6 Allergan Competitive Strengths & Weaknesses
7.10 Re-Vana Therapeutics
7.10.1 Re-Vana Therapeutics Details
7.10.2 Re-Vana Therapeutics Major Business
7.10.3 Re-Vana Therapeutics Biodurable Ophthalmic Drug Delivery System Product and Services
7.10.4 Re-Vana Therapeutics Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Re-Vana Therapeutics Recent Developments/Updates
7.10.6 Re-Vana Therapeutics Competitive Strengths & Weaknesses
7.11 PolyActiva
7.11.1 PolyActiva Details
7.11.2 PolyActiva Major Business
7.11.3 PolyActiva Biodurable Ophthalmic Drug Delivery System Product and Services
7.11.4 PolyActiva Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 PolyActiva Recent Developments/Updates
7.11.6 PolyActiva Competitive Strengths & Weaknesses
7.12 Genentech
7.12.1 Genentech Details
7.12.2 Genentech Major Business
7.12.3 Genentech Biodurable Ophthalmic Drug Delivery System Product and Services
7.12.4 Genentech Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Genentech Recent Developments/Updates
7.12.6 Genentech Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Biodurable Ophthalmic Drug Delivery System and Key Manufacturers
8.2 Biodurable Ophthalmic Drug Delivery System Manufacturing Costs
8.3 Biodurable Ophthalmic Drug Delivery System Production Process
8.4 Biodurable Ophthalmic Drug Delivery System Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Biodurable Ophthalmic Drug Delivery System Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Biodurable Ophthalmic Drug Delivery System Typical Distributors
9.3 Biodurable Ophthalmic Drug Delivery System Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Biodurable Ophthalmic Drug Delivery System Introduction
1.2 World Biodurable Ophthalmic Drug Delivery System Supply & Forecast
1.2.1 World Biodurable Ophthalmic Drug Delivery System Production Value (2017 & 2021 & 2028)
1.2.2 World Biodurable Ophthalmic Drug Delivery System Production (2017-2028)
1.2.3 World Biodurable Ophthalmic Drug Delivery System Pricing Trends (2017-2028)
1.3 World Biodurable Ophthalmic Drug Delivery System Production by Region
1.3.1 World Biodurable Ophthalmic Drug Delivery System Production Value by Region (2017-2028)
1.3.2 World Biodurable Ophthalmic Drug Delivery System Production by Region (2017-2028)
1.3.3 World Biodurable Ophthalmic Drug Delivery System Average Price by Region (2017-2028)
1.3.4 North America Biodurable Ophthalmic Drug Delivery System Production (2017-2028)
1.3.5 Europe Biodurable Ophthalmic Drug Delivery System Production (2017-2028)
1.3.6 China Biodurable Ophthalmic Drug Delivery System Production (2017-2028)
1.3.7 Japan Biodurable Ophthalmic Drug Delivery System Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biodurable Ophthalmic Drug Delivery System Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biodurable Ophthalmic Drug Delivery System Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Biodurable Ophthalmic Drug Delivery System Demand (2017-2028)
2.2 World Biodurable Ophthalmic Drug Delivery System Consumption by Region
2.2.1 World Biodurable Ophthalmic Drug Delivery System Consumption by Region (2017-2022)
2.2.2 World Biodurable Ophthalmic Drug Delivery System Consumption Forecast by Region (2023-2028)
2.3 United States Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028)
2.4 China Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028)
2.5 Europe Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028)
2.6 Japan Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028)
2.7 South Korea Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028)
2.8 ASEAN Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028)
2.9 India Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028)
3 WORLD BIODURABLE OPHTHALMIC DRUG DELIVERY SYSTEM MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Biodurable Ophthalmic Drug Delivery System Production Value by Manufacturer (2017-2022)
3.2 World Biodurable Ophthalmic Drug Delivery System Production by Manufacturer (2017-2022)
3.3 World Biodurable Ophthalmic Drug Delivery System Average Price by Manufacturer (2017-2022)
3.4 Biodurable Ophthalmic Drug Delivery System Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Biodurable Ophthalmic Drug Delivery System Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Biodurable Ophthalmic Drug Delivery System in 2021
3.5.3 Global Concentration Ratios (CR8) for Biodurable Ophthalmic Drug Delivery System in 2021
3.6 Biodurable Ophthalmic Drug Delivery System Market: Overall Company Footprint Analysis
3.6.1 Biodurable Ophthalmic Drug Delivery System Market: Region Footprint
3.6.2 Biodurable Ophthalmic Drug Delivery System Market: Company Product Type Footprint
3.6.3 Biodurable Ophthalmic Drug Delivery System Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Biodurable Ophthalmic Drug Delivery System Production Value Comparison
4.1.1 United States VS China: Biodurable Ophthalmic Drug Delivery System Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Biodurable Ophthalmic Drug Delivery System Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Biodurable Ophthalmic Drug Delivery System Production Comparison
4.2.1 United States VS China: Biodurable Ophthalmic Drug Delivery System Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Biodurable Ophthalmic Drug Delivery System Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Biodurable Ophthalmic Drug Delivery System Consumption Comparison
4.3.1 United States VS China: Biodurable Ophthalmic Drug Delivery System Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Biodurable Ophthalmic Drug Delivery System Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Biodurable Ophthalmic Drug Delivery System Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Biodurable Ophthalmic Drug Delivery System in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Biodurable Ophthalmic Drug Delivery System Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Biodurable Ophthalmic Drug Delivery System Production by Domestic Manufacturer, (2017-2022)
4.5 China Biodurable Ophthalmic Drug Delivery System Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Biodurable Ophthalmic Drug Delivery System in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Biodurable Ophthalmic Drug Delivery System Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Biodurable Ophthalmic Drug Delivery System Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Biodurable Ophthalmic Drug Delivery System Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Biodurable Ophthalmic Drug Delivery System in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Biodurable Ophthalmic Drug Delivery System Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Biodurable Ophthalmic Drug Delivery System Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Biodurable Ophthalmic Drug Delivery System Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Anterior Drug Delivery Methods
5.2.2 Posterior Drug Delivery Methods
5.3 Market Segment by Type
5.3.1 World Biodurable Ophthalmic Drug Delivery System Production by Type (2017-2028)
5.3.2 World Biodurable Ophthalmic Drug Delivery System Production Value by Type (2017-2028)
5.3.3 World Biodurable Ophthalmic Drug Delivery System Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biodurable Ophthalmic Drug Delivery System Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Biodurable Ophthalmic Drug Delivery System Production by Application (2017-2028)
6.3.2 World Biodurable Ophthalmic Drug Delivery System Production Value by Application (2017-2028)
6.3.3 World Biodurable Ophthalmic Drug Delivery System Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Glaukos Corp
7.1.1 Glaukos Corp Details
7.1.2 Glaukos Corp Major Business
7.1.3 Glaukos Corp Biodurable Ophthalmic Drug Delivery System Product and Services
7.1.4 Glaukos Corp Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Glaukos Corp Recent Developments/Updates
7.1.6 Glaukos Corp Competitive Strengths & Weaknesses
7.2 Ocular Therapeutix
7.2.1 Ocular Therapeutix Details
7.2.2 Ocular Therapeutix Major Business
7.2.3 Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System Product and Services
7.2.4 Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Ocular Therapeutix Recent Developments/Updates
7.2.6 Ocular Therapeutix Competitive Strengths & Weaknesses
7.3 Santen Pharmaceutical
7.3.1 Santen Pharmaceutical Details
7.3.2 Santen Pharmaceutical Major Business
7.3.3 Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System Product and Services
7.3.4 Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Santen Pharmaceutical Recent Developments/Updates
7.3.6 Santen Pharmaceutical Competitive Strengths & Weaknesses
7.4 pSivida
7.4.1 pSivida Details
7.4.2 pSivida Major Business
7.4.3 pSivida Biodurable Ophthalmic Drug Delivery System Product and Services
7.4.4 pSivida Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 pSivida Recent Developments/Updates
7.4.6 pSivida Competitive Strengths & Weaknesses
7.5 Clearside Biomedical
7.5.1 Clearside Biomedical Details
7.5.2 Clearside Biomedical Major Business
7.5.3 Clearside Biomedical Biodurable Ophthalmic Drug Delivery System Product and Services
7.5.4 Clearside Biomedical Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Clearside Biomedical Recent Developments/Updates
7.5.6 Clearside Biomedical Competitive Strengths & Weaknesses
7.6 Bausch Health
7.6.1 Bausch Health Details
7.6.2 Bausch Health Major Business
7.6.3 Bausch Health Biodurable Ophthalmic Drug Delivery System Product and Services
7.6.4 Bausch Health Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Bausch Health Recent Developments/Updates
7.6.6 Bausch Health Competitive Strengths & Weaknesses
7.7 AptarGroup
7.7.1 AptarGroup Details
7.7.2 AptarGroup Major Business
7.7.3 AptarGroup Biodurable Ophthalmic Drug Delivery System Product and Services
7.7.4 AptarGroup Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 AptarGroup Recent Developments/Updates
7.7.6 AptarGroup Competitive Strengths & Weaknesses
7.8 Boehringer Ingelheim
7.8.1 Boehringer Ingelheim Details
7.8.2 Boehringer Ingelheim Major Business
7.8.3 Boehringer Ingelheim Biodurable Ophthalmic Drug Delivery System Product and Services
7.8.4 Boehringer Ingelheim Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Boehringer Ingelheim Recent Developments/Updates
7.8.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.9 Allergan
7.9.1 Allergan Details
7.9.2 Allergan Major Business
7.9.3 Allergan Biodurable Ophthalmic Drug Delivery System Product and Services
7.9.4 Allergan Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Allergan Recent Developments/Updates
7.9.6 Allergan Competitive Strengths & Weaknesses
7.10 Re-Vana Therapeutics
7.10.1 Re-Vana Therapeutics Details
7.10.2 Re-Vana Therapeutics Major Business
7.10.3 Re-Vana Therapeutics Biodurable Ophthalmic Drug Delivery System Product and Services
7.10.4 Re-Vana Therapeutics Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Re-Vana Therapeutics Recent Developments/Updates
7.10.6 Re-Vana Therapeutics Competitive Strengths & Weaknesses
7.11 PolyActiva
7.11.1 PolyActiva Details
7.11.2 PolyActiva Major Business
7.11.3 PolyActiva Biodurable Ophthalmic Drug Delivery System Product and Services
7.11.4 PolyActiva Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 PolyActiva Recent Developments/Updates
7.11.6 PolyActiva Competitive Strengths & Weaknesses
7.12 Genentech
7.12.1 Genentech Details
7.12.2 Genentech Major Business
7.12.3 Genentech Biodurable Ophthalmic Drug Delivery System Product and Services
7.12.4 Genentech Biodurable Ophthalmic Drug Delivery System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Genentech Recent Developments/Updates
7.12.6 Genentech Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Biodurable Ophthalmic Drug Delivery System and Key Manufacturers
8.2 Biodurable Ophthalmic Drug Delivery System Manufacturing Costs
8.3 Biodurable Ophthalmic Drug Delivery System Production Process
8.4 Biodurable Ophthalmic Drug Delivery System Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Biodurable Ophthalmic Drug Delivery System Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Biodurable Ophthalmic Drug Delivery System Typical Distributors
9.3 Biodurable Ophthalmic Drug Delivery System Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Biodurable Ophthalmic Drug Delivery System Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Biodurable Ophthalmic Drug Delivery System Production Value by Region (2017-2022) & (USD Million)
Table 3. World Biodurable Ophthalmic Drug Delivery System Production Value by Region (2023-2028) & (USD Million)
Table 4. World Biodurable Ophthalmic Drug Delivery System Production Value Market Share by Region (2017-2022)
Table 5. World Biodurable Ophthalmic Drug Delivery System Production Value Market Share by Region (2023-2028)
Table 6. World Biodurable Ophthalmic Drug Delivery System Production by Region (2017-2022) & (K Units)
Table 7. World Biodurable Ophthalmic Drug Delivery System Production by Region (2023-2028) & (K Units)
Table 8. World Biodurable Ophthalmic Drug Delivery System Production Market Share by Region (2017-2022)
Table 9. World Biodurable Ophthalmic Drug Delivery System Production Market Share by Region (2023-2028)
Table 10. World Biodurable Ophthalmic Drug Delivery System Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Biodurable Ophthalmic Drug Delivery System Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Biodurable Ophthalmic Drug Delivery System Major Market Trends
Table 13. World Biodurable Ophthalmic Drug Delivery System Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Biodurable Ophthalmic Drug Delivery System Consumption by Region (2017-2022) & (K Units)
Table 15. World Biodurable Ophthalmic Drug Delivery System Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Biodurable Ophthalmic Drug Delivery System Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Biodurable Ophthalmic Drug Delivery System Producers in 2021
Table 18. World Biodurable Ophthalmic Drug Delivery System Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Biodurable Ophthalmic Drug Delivery System Producers in 2021
Table 20. World Biodurable Ophthalmic Drug Delivery System Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Biodurable Ophthalmic Drug Delivery System Company Evaluation Quadrant
Table 22. World Biodurable Ophthalmic Drug Delivery System Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Biodurable Ophthalmic Drug Delivery System Production Site of Key Manufacturer
Table 24. Biodurable Ophthalmic Drug Delivery System Market: Company Product Type Footprint
Table 25. Biodurable Ophthalmic Drug Delivery System Market: Company Product Application Footprint
Table 26. Biodurable Ophthalmic Drug Delivery System Competitive Factors
Table 27. Biodurable Ophthalmic Drug Delivery System New Entrant and Capacity Expansion Plans
Table 28. Biodurable Ophthalmic Drug Delivery System Mergers & Acquisitions Activity
Table 29. United States VS China Biodurable Ophthalmic Drug Delivery System Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Biodurable Ophthalmic Drug Delivery System Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Biodurable Ophthalmic Drug Delivery System Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Biodurable Ophthalmic Drug Delivery System in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Biodurable Ophthalmic Drug Delivery System Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Biodurable Ophthalmic Drug Delivery System Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Biodurable Ophthalmic Drug Delivery System Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Biodurable Ophthalmic Drug Delivery System Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Biodurable Ophthalmic Drug Delivery System in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Biodurable Ophthalmic Drug Delivery System Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Biodurable Ophthalmic Drug Delivery System Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Biodurable Ophthalmic Drug Delivery System Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Biodurable Ophthalmic Drug Delivery System Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Biodurable Ophthalmic Drug Delivery System in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Biodurable Ophthalmic Drug Delivery System Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Biodurable Ophthalmic Drug Delivery System Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Biodurable Ophthalmic Drug Delivery System Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Biodurable Ophthalmic Drug Delivery System Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Biodurable Ophthalmic Drug Delivery System Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Biodurable Ophthalmic Drug Delivery System Production by Type (2017-2022) & (K Units)
Table 49. World Biodurable Ophthalmic Drug Delivery System Production by Type (2023-2028) & (K Units)
Table 50. World Biodurable Ophthalmic Drug Delivery System Production Value by Type (2017-2022) & (USD Million)
Table 51. World Biodurable Ophthalmic Drug Delivery System Production Value by Type (2023-2028) & (USD Million)
Table 52. World Biodurable Ophthalmic Drug Delivery System Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Biodurable Ophthalmic Drug Delivery System Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Biodurable Ophthalmic Drug Delivery System Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Biodurable Ophthalmic Drug Delivery System Production by Application (2017-2022) & (K Units)
Table 56. World Biodurable Ophthalmic Drug Delivery System Production by Application (2023-2028) & (K Units)
Table 57. World Biodurable Ophthalmic Drug Delivery System Production Value by Application (2017-2022) & (USD Million)
Table 58. World Biodurable Ophthalmic Drug Delivery System Production Value by Application (2023-2028) & (USD Million)
Table 59. World Biodurable Ophthalmic Drug Delivery System Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Biodurable Ophthalmic Drug Delivery System Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Glaukos Corp Basic Information, Manufacturing Base and Competitors
Table 62. Glaukos Corp Major Business
Table 63. Glaukos Corp Biodurable Ophthalmic Drug Delivery System Product and Services
Table 64. Glaukos Corp Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Glaukos Corp Recent Developments/Updates
Table 66. Glaukos Corp Competitive Strengths & Weaknesses
Table 67. Ocular Therapeutix Basic Information, Manufacturing Base and Competitors
Table 68. Ocular Therapeutix Major Business
Table 69. Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System Product and Services
Table 70. Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Ocular Therapeutix Recent Developments/Updates
Table 72. Ocular Therapeutix Competitive Strengths & Weaknesses
Table 73. Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Santen Pharmaceutical Major Business
Table 75. Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System Product and Services
Table 76. Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Santen Pharmaceutical Recent Developments/Updates
Table 78. Santen Pharmaceutical Competitive Strengths & Weaknesses
Table 79. pSivida Basic Information, Manufacturing Base and Competitors
Table 80. pSivida Major Business
Table 81. pSivida Biodurable Ophthalmic Drug Delivery System Product and Services
Table 82. pSivida Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. pSivida Recent Developments/Updates
Table 84. pSivida Competitive Strengths & Weaknesses
Table 85. Clearside Biomedical Basic Information, Manufacturing Base and Competitors
Table 86. Clearside Biomedical Major Business
Table 87. Clearside Biomedical Biodurable Ophthalmic Drug Delivery System Product and Services
Table 88. Clearside Biomedical Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Clearside Biomedical Recent Developments/Updates
Table 90. Clearside Biomedical Competitive Strengths & Weaknesses
Table 91. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 92. Bausch Health Major Business
Table 93. Bausch Health Biodurable Ophthalmic Drug Delivery System Product and Services
Table 94. Bausch Health Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Bausch Health Recent Developments/Updates
Table 96. Bausch Health Competitive Strengths & Weaknesses
Table 97. AptarGroup Basic Information, Manufacturing Base and Competitors
Table 98. AptarGroup Major Business
Table 99. AptarGroup Biodurable Ophthalmic Drug Delivery System Product and Services
Table 100. AptarGroup Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. AptarGroup Recent Developments/Updates
Table 102. AptarGroup Competitive Strengths & Weaknesses
Table 103. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 104. Boehringer Ingelheim Major Business
Table 105. Boehringer Ingelheim Biodurable Ophthalmic Drug Delivery System Product and Services
Table 106. Boehringer Ingelheim Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Boehringer Ingelheim Recent Developments/Updates
Table 108. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 109. Allergan Basic Information, Manufacturing Base and Competitors
Table 110. Allergan Major Business
Table 111. Allergan Biodurable Ophthalmic Drug Delivery System Product and Services
Table 112. Allergan Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Allergan Recent Developments/Updates
Table 114. Allergan Competitive Strengths & Weaknesses
Table 115. Re-Vana Therapeutics Basic Information, Manufacturing Base and Competitors
Table 116. Re-Vana Therapeutics Major Business
Table 117. Re-Vana Therapeutics Biodurable Ophthalmic Drug Delivery System Product and Services
Table 118. Re-Vana Therapeutics Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Re-Vana Therapeutics Recent Developments/Updates
Table 120. Re-Vana Therapeutics Competitive Strengths & Weaknesses
Table 121. PolyActiva Basic Information, Manufacturing Base and Competitors
Table 122. PolyActiva Major Business
Table 123. PolyActiva Biodurable Ophthalmic Drug Delivery System Product and Services
Table 124. PolyActiva Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. PolyActiva Recent Developments/Updates
Table 126. Genentech Basic Information, Manufacturing Base and Competitors
Table 127. Genentech Major Business
Table 128. Genentech Biodurable Ophthalmic Drug Delivery System Product and Services
Table 129. Genentech Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 130. Biodurable Ophthalmic Drug Delivery System Raw Material
Table 131. Key Manufacturers of Biodurable Ophthalmic Drug Delivery System Raw Materials
Table 132. Biodurable Ophthalmic Drug Delivery System Typical Distributors
Table 133. Biodurable Ophthalmic Drug Delivery System Typical Customers
Table 1. World Biodurable Ophthalmic Drug Delivery System Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Biodurable Ophthalmic Drug Delivery System Production Value by Region (2017-2022) & (USD Million)
Table 3. World Biodurable Ophthalmic Drug Delivery System Production Value by Region (2023-2028) & (USD Million)
Table 4. World Biodurable Ophthalmic Drug Delivery System Production Value Market Share by Region (2017-2022)
Table 5. World Biodurable Ophthalmic Drug Delivery System Production Value Market Share by Region (2023-2028)
Table 6. World Biodurable Ophthalmic Drug Delivery System Production by Region (2017-2022) & (K Units)
Table 7. World Biodurable Ophthalmic Drug Delivery System Production by Region (2023-2028) & (K Units)
Table 8. World Biodurable Ophthalmic Drug Delivery System Production Market Share by Region (2017-2022)
Table 9. World Biodurable Ophthalmic Drug Delivery System Production Market Share by Region (2023-2028)
Table 10. World Biodurable Ophthalmic Drug Delivery System Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Biodurable Ophthalmic Drug Delivery System Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Biodurable Ophthalmic Drug Delivery System Major Market Trends
Table 13. World Biodurable Ophthalmic Drug Delivery System Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Biodurable Ophthalmic Drug Delivery System Consumption by Region (2017-2022) & (K Units)
Table 15. World Biodurable Ophthalmic Drug Delivery System Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Biodurable Ophthalmic Drug Delivery System Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Biodurable Ophthalmic Drug Delivery System Producers in 2021
Table 18. World Biodurable Ophthalmic Drug Delivery System Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Biodurable Ophthalmic Drug Delivery System Producers in 2021
Table 20. World Biodurable Ophthalmic Drug Delivery System Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Biodurable Ophthalmic Drug Delivery System Company Evaluation Quadrant
Table 22. World Biodurable Ophthalmic Drug Delivery System Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Biodurable Ophthalmic Drug Delivery System Production Site of Key Manufacturer
Table 24. Biodurable Ophthalmic Drug Delivery System Market: Company Product Type Footprint
Table 25. Biodurable Ophthalmic Drug Delivery System Market: Company Product Application Footprint
Table 26. Biodurable Ophthalmic Drug Delivery System Competitive Factors
Table 27. Biodurable Ophthalmic Drug Delivery System New Entrant and Capacity Expansion Plans
Table 28. Biodurable Ophthalmic Drug Delivery System Mergers & Acquisitions Activity
Table 29. United States VS China Biodurable Ophthalmic Drug Delivery System Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Biodurable Ophthalmic Drug Delivery System Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Biodurable Ophthalmic Drug Delivery System Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Biodurable Ophthalmic Drug Delivery System in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Biodurable Ophthalmic Drug Delivery System Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Biodurable Ophthalmic Drug Delivery System Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Biodurable Ophthalmic Drug Delivery System Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Biodurable Ophthalmic Drug Delivery System Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Biodurable Ophthalmic Drug Delivery System in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Biodurable Ophthalmic Drug Delivery System Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Biodurable Ophthalmic Drug Delivery System Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Biodurable Ophthalmic Drug Delivery System Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Biodurable Ophthalmic Drug Delivery System Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Biodurable Ophthalmic Drug Delivery System in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Biodurable Ophthalmic Drug Delivery System Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Biodurable Ophthalmic Drug Delivery System Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Biodurable Ophthalmic Drug Delivery System Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Biodurable Ophthalmic Drug Delivery System Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Biodurable Ophthalmic Drug Delivery System Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Biodurable Ophthalmic Drug Delivery System Production by Type (2017-2022) & (K Units)
Table 49. World Biodurable Ophthalmic Drug Delivery System Production by Type (2023-2028) & (K Units)
Table 50. World Biodurable Ophthalmic Drug Delivery System Production Value by Type (2017-2022) & (USD Million)
Table 51. World Biodurable Ophthalmic Drug Delivery System Production Value by Type (2023-2028) & (USD Million)
Table 52. World Biodurable Ophthalmic Drug Delivery System Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Biodurable Ophthalmic Drug Delivery System Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Biodurable Ophthalmic Drug Delivery System Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Biodurable Ophthalmic Drug Delivery System Production by Application (2017-2022) & (K Units)
Table 56. World Biodurable Ophthalmic Drug Delivery System Production by Application (2023-2028) & (K Units)
Table 57. World Biodurable Ophthalmic Drug Delivery System Production Value by Application (2017-2022) & (USD Million)
Table 58. World Biodurable Ophthalmic Drug Delivery System Production Value by Application (2023-2028) & (USD Million)
Table 59. World Biodurable Ophthalmic Drug Delivery System Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Biodurable Ophthalmic Drug Delivery System Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Glaukos Corp Basic Information, Manufacturing Base and Competitors
Table 62. Glaukos Corp Major Business
Table 63. Glaukos Corp Biodurable Ophthalmic Drug Delivery System Product and Services
Table 64. Glaukos Corp Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Glaukos Corp Recent Developments/Updates
Table 66. Glaukos Corp Competitive Strengths & Weaknesses
Table 67. Ocular Therapeutix Basic Information, Manufacturing Base and Competitors
Table 68. Ocular Therapeutix Major Business
Table 69. Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System Product and Services
Table 70. Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Ocular Therapeutix Recent Developments/Updates
Table 72. Ocular Therapeutix Competitive Strengths & Weaknesses
Table 73. Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Santen Pharmaceutical Major Business
Table 75. Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System Product and Services
Table 76. Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Santen Pharmaceutical Recent Developments/Updates
Table 78. Santen Pharmaceutical Competitive Strengths & Weaknesses
Table 79. pSivida Basic Information, Manufacturing Base and Competitors
Table 80. pSivida Major Business
Table 81. pSivida Biodurable Ophthalmic Drug Delivery System Product and Services
Table 82. pSivida Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. pSivida Recent Developments/Updates
Table 84. pSivida Competitive Strengths & Weaknesses
Table 85. Clearside Biomedical Basic Information, Manufacturing Base and Competitors
Table 86. Clearside Biomedical Major Business
Table 87. Clearside Biomedical Biodurable Ophthalmic Drug Delivery System Product and Services
Table 88. Clearside Biomedical Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Clearside Biomedical Recent Developments/Updates
Table 90. Clearside Biomedical Competitive Strengths & Weaknesses
Table 91. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 92. Bausch Health Major Business
Table 93. Bausch Health Biodurable Ophthalmic Drug Delivery System Product and Services
Table 94. Bausch Health Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Bausch Health Recent Developments/Updates
Table 96. Bausch Health Competitive Strengths & Weaknesses
Table 97. AptarGroup Basic Information, Manufacturing Base and Competitors
Table 98. AptarGroup Major Business
Table 99. AptarGroup Biodurable Ophthalmic Drug Delivery System Product and Services
Table 100. AptarGroup Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. AptarGroup Recent Developments/Updates
Table 102. AptarGroup Competitive Strengths & Weaknesses
Table 103. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 104. Boehringer Ingelheim Major Business
Table 105. Boehringer Ingelheim Biodurable Ophthalmic Drug Delivery System Product and Services
Table 106. Boehringer Ingelheim Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Boehringer Ingelheim Recent Developments/Updates
Table 108. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 109. Allergan Basic Information, Manufacturing Base and Competitors
Table 110. Allergan Major Business
Table 111. Allergan Biodurable Ophthalmic Drug Delivery System Product and Services
Table 112. Allergan Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Allergan Recent Developments/Updates
Table 114. Allergan Competitive Strengths & Weaknesses
Table 115. Re-Vana Therapeutics Basic Information, Manufacturing Base and Competitors
Table 116. Re-Vana Therapeutics Major Business
Table 117. Re-Vana Therapeutics Biodurable Ophthalmic Drug Delivery System Product and Services
Table 118. Re-Vana Therapeutics Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Re-Vana Therapeutics Recent Developments/Updates
Table 120. Re-Vana Therapeutics Competitive Strengths & Weaknesses
Table 121. PolyActiva Basic Information, Manufacturing Base and Competitors
Table 122. PolyActiva Major Business
Table 123. PolyActiva Biodurable Ophthalmic Drug Delivery System Product and Services
Table 124. PolyActiva Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. PolyActiva Recent Developments/Updates
Table 126. Genentech Basic Information, Manufacturing Base and Competitors
Table 127. Genentech Major Business
Table 128. Genentech Biodurable Ophthalmic Drug Delivery System Product and Services
Table 129. Genentech Biodurable Ophthalmic Drug Delivery System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 130. Biodurable Ophthalmic Drug Delivery System Raw Material
Table 131. Key Manufacturers of Biodurable Ophthalmic Drug Delivery System Raw Materials
Table 132. Biodurable Ophthalmic Drug Delivery System Typical Distributors
Table 133. Biodurable Ophthalmic Drug Delivery System Typical Customers
LIST OF FIGURES
Figure 1. Biodurable Ophthalmic Drug Delivery System Picture
Figure 2. World Biodurable Ophthalmic Drug Delivery System Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Biodurable Ophthalmic Drug Delivery System Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Biodurable Ophthalmic Drug Delivery System Production (2017-2028) & (K Units)
Figure 5. World Biodurable Ophthalmic Drug Delivery System Average Price (2017-2028) & (US$/Unit)
Figure 6. World Biodurable Ophthalmic Drug Delivery System Production Value Market Share by Region (2017-2028)
Figure 7. World Biodurable Ophthalmic Drug Delivery System Production Market Share by Region (2017-2028)
Figure 8. North America Biodurable Ophthalmic Drug Delivery System Production (2017-2028) & (K Units)
Figure 9. Europe Biodurable Ophthalmic Drug Delivery System Production (2017-2028) & (K Units)
Figure 10. China Biodurable Ophthalmic Drug Delivery System Production (2017-2028) & (K Units)
Figure 11. Japan Biodurable Ophthalmic Drug Delivery System Production (2017-2028) & (K Units)
Figure 12. Biodurable Ophthalmic Drug Delivery System Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Biodurable Ophthalmic Drug Delivery System Demand (2017-2028) & (K Units)
Figure 15. World Biodurable Ophthalmic Drug Delivery System Consumption Market Share by Region (2017-2028)
Figure 16. United States Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028) & (K Units)
Figure 17. China Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028) & (K Units)
Figure 18. Europe Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028) & (K Units)
Figure 19. Japan Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028) & (K Units)
Figure 20. South Korea Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028) & (K Units)
Figure 22. India Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Biodurable Ophthalmic Drug Delivery System by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Biodurable Ophthalmic Drug Delivery System Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Biodurable Ophthalmic Drug Delivery System Markets in 2021
Figure 26. United States VS China: Biodurable Ophthalmic Drug Delivery System Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Biodurable Ophthalmic Drug Delivery System Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Biodurable Ophthalmic Drug Delivery System Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Biodurable Ophthalmic Drug Delivery System in United States
Figure 30. Key Producers and Market Share of Biodurable Ophthalmic Drug Delivery System in China
Figure 31. Key Producers and Market Share of Biodurable Ophthalmic Drug Delivery System in Rest of World
Figure 32. World Biodurable Ophthalmic Drug Delivery System Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Biodurable Ophthalmic Drug Delivery System Production Value Market Share by Type in 2021
Figure 34. Anterior Drug Delivery Methods
Figure 35. Posterior Drug Delivery Methods
Figure 36. World Biodurable Ophthalmic Drug Delivery System Production Market Share by Type (2017-2028)
Figure 37. World Biodurable Ophthalmic Drug Delivery System Production Value Market Share by Type (2017-2028)
Figure 38. World Biodurable Ophthalmic Drug Delivery System Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Biodurable Ophthalmic Drug Delivery System Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Biodurable Ophthalmic Drug Delivery System Production Value Market Share by Application in 2021
Figure 41. Hospitals
Figure 42. Clinics
Figure 43. Others
Figure 44. World Biodurable Ophthalmic Drug Delivery System Production Market Share by Application (2017-2028)
Figure 45. World Biodurable Ophthalmic Drug Delivery System Production Value Market Share by Application (2017-2028)
Figure 46. World Biodurable Ophthalmic Drug Delivery System Average Price by Application (2017-2028) & (US$/Unit)
Figure 47. Manufacturing Cost Structure Analysis of Biodurable Ophthalmic Drug Delivery System in 2021
Figure 48. Manufacturing Process Analysis of Biodurable Ophthalmic Drug Delivery System
Figure 49. Biodurable Ophthalmic Drug Delivery System Industrial Chain
Figure 50. Distribution Channel Breakdown for Biodurable Ophthalmic Drug Delivery System Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Biodurable Ophthalmic Drug Delivery System Picture
Figure 2. World Biodurable Ophthalmic Drug Delivery System Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Biodurable Ophthalmic Drug Delivery System Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Biodurable Ophthalmic Drug Delivery System Production (2017-2028) & (K Units)
Figure 5. World Biodurable Ophthalmic Drug Delivery System Average Price (2017-2028) & (US$/Unit)
Figure 6. World Biodurable Ophthalmic Drug Delivery System Production Value Market Share by Region (2017-2028)
Figure 7. World Biodurable Ophthalmic Drug Delivery System Production Market Share by Region (2017-2028)
Figure 8. North America Biodurable Ophthalmic Drug Delivery System Production (2017-2028) & (K Units)
Figure 9. Europe Biodurable Ophthalmic Drug Delivery System Production (2017-2028) & (K Units)
Figure 10. China Biodurable Ophthalmic Drug Delivery System Production (2017-2028) & (K Units)
Figure 11. Japan Biodurable Ophthalmic Drug Delivery System Production (2017-2028) & (K Units)
Figure 12. Biodurable Ophthalmic Drug Delivery System Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Biodurable Ophthalmic Drug Delivery System Demand (2017-2028) & (K Units)
Figure 15. World Biodurable Ophthalmic Drug Delivery System Consumption Market Share by Region (2017-2028)
Figure 16. United States Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028) & (K Units)
Figure 17. China Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028) & (K Units)
Figure 18. Europe Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028) & (K Units)
Figure 19. Japan Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028) & (K Units)
Figure 20. South Korea Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028) & (K Units)
Figure 22. India Biodurable Ophthalmic Drug Delivery System Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Biodurable Ophthalmic Drug Delivery System by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Biodurable Ophthalmic Drug Delivery System Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Biodurable Ophthalmic Drug Delivery System Markets in 2021
Figure 26. United States VS China: Biodurable Ophthalmic Drug Delivery System Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Biodurable Ophthalmic Drug Delivery System Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Biodurable Ophthalmic Drug Delivery System Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Biodurable Ophthalmic Drug Delivery System in United States
Figure 30. Key Producers and Market Share of Biodurable Ophthalmic Drug Delivery System in China
Figure 31. Key Producers and Market Share of Biodurable Ophthalmic Drug Delivery System in Rest of World
Figure 32. World Biodurable Ophthalmic Drug Delivery System Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Biodurable Ophthalmic Drug Delivery System Production Value Market Share by Type in 2021
Figure 34. Anterior Drug Delivery Methods
Figure 35. Posterior Drug Delivery Methods
Figure 36. World Biodurable Ophthalmic Drug Delivery System Production Market Share by Type (2017-2028)
Figure 37. World Biodurable Ophthalmic Drug Delivery System Production Value Market Share by Type (2017-2028)
Figure 38. World Biodurable Ophthalmic Drug Delivery System Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Biodurable Ophthalmic Drug Delivery System Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Biodurable Ophthalmic Drug Delivery System Production Value Market Share by Application in 2021
Figure 41. Hospitals
Figure 42. Clinics
Figure 43. Others
Figure 44. World Biodurable Ophthalmic Drug Delivery System Production Market Share by Application (2017-2028)
Figure 45. World Biodurable Ophthalmic Drug Delivery System Production Value Market Share by Application (2017-2028)
Figure 46. World Biodurable Ophthalmic Drug Delivery System Average Price by Application (2017-2028) & (US$/Unit)
Figure 47. Manufacturing Cost Structure Analysis of Biodurable Ophthalmic Drug Delivery System in 2021
Figure 48. Manufacturing Process Analysis of Biodurable Ophthalmic Drug Delivery System
Figure 49. Biodurable Ophthalmic Drug Delivery System Industrial Chain
Figure 50. Distribution Channel Breakdown for Biodurable Ophthalmic Drug Delivery System Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source
